Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 2061-2080 of 3,347 trials

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NCT04089761

Nerivio™ is an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine with or without aura in patients 18 years old or above who do not have chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. This is a prospective, single arm, open label, multicenter trial of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents The study will be conducted in three phases: Phase I - Run-in: Phase II - Treatment phase: Phase III (optional) - Free-use

Acute Migraine

Theranica60 participantsStarted Oct 2019

Aurora, Colorado, United States • Hialeah, Florida, United States • Miami, Florida, United States +9 more locations

UNKNOWNPhase 1< 1 mile

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

NCT02135588

The purpose of this study is to evaluate the efficacy and safety of intrapleural dornase alfa and tPA administered to patients with clinical failure of small-bore chest tube with persistent pleural effusions or malignancy-related loculated effusion to improve pleural drainage.

Loculated or Non-draining Malignant Pleural Effusions

Eastern Regional Medical Center10 participantsStarted Oct 2013

Philadelphia, Pennsylvania, United States

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

Rheumatoid Arthritis Trials in Other Cities

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Start Time Optimization of Biologics in Polyarticular JIA

Distal Radius Buckle Fracture RCT

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Self-directed Video Versus Instructor-based Neonatal Resuscitation Training

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

Surgical Pain After Inguinal Hernia Repair (SPAIHR)

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

P4 (Pregabalin for Peripheral Posttraumatic Pain)

Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.

Other Conditions in Philadelphia